
==== Front
Eur Respir Rev
Eur Respir Rev
ERR
errev
European Respiratory Review
0905-9180
1600-0617
European Respiratory Society

10.1183/16000617.0259-2023
ERR-0259-2023
Version of Record
Reviews
11
Fine particulate matter manipulates immune response to exacerbate microbial pathogenesis in the respiratory tract
PM2.5 and microbial pathogenesis in the respiratory tract
Ma Jason 110
Chiu Ya-Fang 1234510
Kao Chih-Chen 6
Chuang Chun-Ning 2
Chen Chi-Yuan 1
https://orcid.org/0000-0001-7145-784X
Lai Chih-Ho 12347810
Kuo Ming-Ling 129
1 Department of Microbiology and Immunology, Chang Gung University, Taoyuan, Taiwan
2 Graduate Institute of Biomedical Sciences, Chang Gung University, Taoyuan, Taiwan
3 Research Center for Emerging Viral Infections, Chang Gung University, Taoyuan, Taiwan
4 Department of Laboratory Medicine, Molecular Infectious Disease Research Center, Chang Gung Memorial Hospital, Linkou, Taiwan
5 Division of Infectious Diseases, Department of Medicine, Chang Gung Memorial Hospital, New Taipei, Taiwan
6 School of Medicine, College of Medicine, Chang Gung University, Taoyuan, Taiwan
7 Department of Microbiology and Immunology, School of Medicine, China Medical University, Taichung, Taiwan
8 Department of Nursing, Asia University, Taichung, Taiwan
9 Division of Allergy, Asthma, and Rheumatology, Department of Pediatrics, Chang Gung Memorial Hospital, Linkou, Taiwan
10 Equal contribution to this work
Corresponding author: Ming-Ling Kuo (mingling@mail.cgu.edu.tw)
7 2024
04 9 2024
33 173 23025915 12 2023
18 6 2024
Copyright ©The authors 2024
2024
https://creativecommons.org/licenses/by-nc/4.0/ This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org
Particulate matter with a diameter ≤2.5 μm (PM2.5) poses a substantial global challenge, with a growing recognition of pathogens contributing to diseases associated with exposure to PM2.5. Recent studies have focused on PM2.5, which impairs the immune cells in response to microbial infections and potentially contributes to the development of severe diseases in the respiratory tract. Accordingly, changes in the respiratory immune function and microecology mediated by PM2.5 are important factors that enhance the risk of microbial pathogenesis. These factors have garnered significant interest. In this review, we summarise recent studies on the potential mechanisms involved in PM2.5-mediated immune system disruption and exacerbation of microbial pathogenesis in the respiratory tract. We also discuss crucial areas for future research to address the gaps in our understanding and develop effective strategies to combat the adverse health effects of PM2.5.

Shareable abstract

PM2.5 exposure significantly impacts the respiratory immune response, increasing susceptibility to microbial infections. This review summarises the mechanisms involved in respiratory health and the need for further research on mitigating these effects. https://bit.ly/3L1Cks2

Chang Gung Medical Foundation http://dx.doi.org/10.13039/501100004606 CMRPD1M0871, BMRPF14, CMRPD1J0021-3 National Science and Technology Council http://dx.doi.org/10.13039/501100020950 112-2320-B-182-033 and 112-2320-B-182-042-MY3
==== Body
pmcIntroduction

Air quality is a crucial issue that warrants concern since the air we breathe can gradually affect our health. According to an estimation made by the World Health Organization (WHO) in 2021 and the Institute for Health Metrics and Evaluation's Global Burden of Disease in 2019, approximately 6–7 million deaths can be attributed to the joint effects of ambient and household air pollution [1]. Crucially, an increase has been noted in both the mortality and disease burden associated with ambient air pollution, whereas these factors decreased for household air pollution [2, 3].

To offer a quantitative, health-based recommendation for air quality, the WHO published air quality guidelines (AQGs) for ambient pollutants in 2005 and updated them in 2021 [4]. These guidelines help regulators formulate policies aimed at reducing the health burden caused by exposure to air pollution. In the AQGs, the levels of particulate matter (PM), ground-level ozone (O3), nitrogen dioxide, sulphur dioxide and carbon monoxide (were listed as major concerns [5]. Research has mostly focused on PM with a diameter ≤2.5 μm (PM2.5), owing to its compositional heterogeneity and severity [6, 7]. More than 90% of the world's population is exposed to higher PM levels compared to the recommendations of the AQGs [8]. High concentrations of PM have been recorded in Southeast Asia, the Eastern Mediterranean and Western Pacific regions, leading to an elevated mortality rate [9]. For PMs, especially PM2.5, approximately 64% of deaths were attributed to ambient air pollution, whereas 36% of deaths were attributed to household air pollution [10]. The welfare losses caused by air pollution were 40% higher than those in the 2013–2016 evaluation and were estimated to be $8.1 trillion, equivalent to 6.1% of the global gross domestic product in 2019 [11]. The highest welfare losses were reported in middle-income countries with ambient air pollution, whereas low-income countries suffered from household air pollution [12]. Consequently, the morbidity and mortality rates of respiratory diseases are major issues affecting individuals with low or medium socioeconomic status who are exposed to poor living conditions [13].

Respiratory diseases comprise three of the top ten causes of death, with COPD being the third, lower respiratory tract infections (LRTIs) being the fourth and pulmonary cancers being the sixth [14]. The Forum of the International Respiratory Society identified five major lung problems, termed the “big five”, and included COPD, asthma, acute LRTIs, tuberculosis and lung cancer [15]. While the exact mechanisms remain unclear, there appears to be an inseparable interaction between exposure to air pollution and respiratory infections in pulmonary infectious diseases, such as bacterial pneumonia or viral infections. This interaction leads to increased severity and mortality [16, 17]. Therefore, we conducted searches for studies on ambient air pollution across three databases, namely PubMed, Web of Science and Cochrane, using the keywords: (“PM2.5” OR “air pollution”) AND (“immune response” OR “immunosuppression” OR “cytokines” OR “innate immunity” OR “adaptive immunity”) AND (“respiratory infections” OR “virus” OR “bacteria”). We then applied database-specific filters to include animal studies, in vitro cell culture experiments and clinical research. Our inclusion criteria were: 1) relevance to the topic and publication before 2024, 2) articles written in English, 3) peer-reviewed animal experiments, cell culture experiments, clinical trials and observational studies, and 4) studies related to respiratory infections. Conversely, exclusion criteria included: 1) studies focusing on nonimmunological parameters or lacking specific immune response outcomes and 2) studies investigating other pollutants. In this review, we discuss how PM2.5 orchestrates immune responses and contributes to the promotion of microbial respiratory infections and pathogenesis.

Composition of PM2.5

PM is a complex mixture of airborne particles and liquid droplets that can be released by primary or secondary resources [18]. Primary resources are linked to anthropogenic factors, such as vehicle usage, industries and residential heating, or natural elements such as windblown dust, pollen, soil erosion, forest fires and dust storms. Secondary resources are formed within the atmosphere via chemical reactions, which generally result in the formation of sulphur dioxide, nitrogen oxides, ammonia and certain organic compounds [19]. The PM categories are characterised by their diameters. PM10, also called coarse particles, are smaller than 10 µm in diameter, PM2.5, referred to as fine particles, are smaller than 2.5 µm in diameter and PM0.1, also called ultrafine particles, are less than 0.1 µm in diameter [20]. The compositions and concentrations of PMs are highly correlated with geographical conditions and climate extremes, and inhaled PMs vary significantly over time and space and may have a remarkably different impact on PM-associated diseases [21, 22]. PM10 is directly emitted from natural sources or activities that disturb nature, whereas PM2.5 is predominantly expelled from anthropogenic sources [23, 24].

By analysing their ion composition, the chemical composition of PMs can be sorted into six categories, as follows: sulphate (assumed to be ammonium sulphate), nitrate (assumed to be ammonium nitrate), organic mass, elemental or black carbon, fine soil, and sea salt (coarse mass) [25]. PMs are usually dominated by organic groups related to urban aerosols, followed by sulphate–nitrate–ammonium ions, which are considered secondary resources in different regions [26, 27]. In contrast, PM10 comprises 10–20% of the ion components originating from fine soil and sea salt, which may originate from sand and dust storms [28]. While PM2.5 poses the greatest danger to human health, PM10–PM2.5 can also be a concern as it can invade the upper airway and the larger airways of the lungs, mediating injury via inflammation or other mechanisms [29, 30].

Several toxic components, including polycyclic aromatic hydrocarbons (PAHs), aliphatic/chlorinated hydrocarbons, nitro PAHs/ketones/quinones and other potential toxic elements (PTEs), such as cadmium, lead [31], zinc [32], nickel, chromium, arsenic or copper, are usually incorporated in the PM2.5. These are enriched and fluctuate in particular regions and different seasons [33–35]. 16 PAHs are listed as high-priority pollutants by the Environmental Protection Agency, including naphthalene, acenaphthylene, acenaphthene, fluorene, phenanthrene, anthracene, fluoranthene, pyrene, benzo[a]anthracene, chrysene, benzo[b]fluoranthene, benzo[k]fluoranthene, benzo[a]pyrene, benzo[g,h,i]perylene, indeno[1,2,3-c,d]pyrene and dibenz[a,h]anthracene, due to their potential toxicity to human and other organisms [36]. PAHs can be further categorised based on their aromatic rings and molecular weight. Low molecular weight (LMW) and intermediate molecular weight (IMW) PAHs are composed of two to three rings and four rings, respectively, and high molecular weight (HMW) PAHs, which contain at least five ring structures, are largely bound to particles. LMW PAHs are typically found in the atmosphere, predominantly in the vapour phase, whereas IMW PAHs are distributed between the vapour and particulate phases [37]. Among these PAHs, benzo[a]pyrene is considered the most toxic with high carcinogenicity [38]. PAHs also mediate the dysfunction of metabolic enzymes and produce reactive oxygen species (ROS) and DNA adducts, triggering inflammation, DNA mutations and tumorigenesis [39, 40].

Meanwhile, the varieties of inflammatory responses or disease outcomes are correlated with PTEs owing to the diverse range of components that are incorporated. For example, cadmium accumulation in immune cells not only alters their ability to secrete cytokines and induces ROS production to trigger cell death, but also influences the frequency and distribution of immune cell subsets that are recruited into the affected tissues or organs [41]. Nickel, chromium and arsenic significantly increase the prevalence of paediatric, acute upper and lower respiratory diseases, and pneumonia during flu seasons [42]. Nevertheless, co-exposure of lead with arsenic, cadmium or mercury induces the onset of asthma [41]. Although more evidence is required, the level of metal ions in PM2.5 may be crucial for evaluating the risk of inflammatory diseases and tumours.

PM2.5 manipulates immune response and promotes disease development

Given its small particle size, 1) the inhaled PM2.5 is not only trapped in the upper respiratory tract and injures the integrity of the epithelial cells and disrupts their functions but is also capable of penetrating into the lower respiratory tract to destroy the alveolar epithelial cells. 2) Although macrophages in the lung play a critical role in eliminating inhaled particles and maintaining immune homeostasis by regulating cytokine secretion, the toxic components embedded in PM2.5 disrupt their phagocytosis and autophagy abilities and even alter their differentiation process. 3) PM2.5 even disrupts the T-helper (Th) 1/Th2 balance of T-cell differentiation, leading to inappropriate cytokine expression, enhanced immune cell infiltration and inflammatory responses in the respiratory tract (figure 1). In addition to severe lung injuries, these dysregulated cytokine secretions induced by PM2.5 are correlated with tumorigenesis. Therefore, in this section, the impact of PM2.5 on immune responses and their associated diseases is discussed.

FIGURE 1 Particulate matter with a diameter ≤2.5 μm (PM2.5) impairs immune function and promotes disease development. Schematic illustration of the mechanism underlying the suppression of the immune system mediated by PM2.5. a) Representation of the respiratory system in a healthy individual and b) The airway status during PM2.5 exposure. Upon exposure, PM2.5 leads to mitochondrial dysfunction and induces reactive oxygen species (ROS) production in epithelial cells. Excessive ROS disrupts the integrity of the epithelial barrier and cilia, which impairs mucociliary clearance and allows bacteria to adhere to and colonise the upper respiratory tract. PM2.5 even penetrates deeply into the lower respiratory tract to irradiate the alveolar epithelial cells and trigger ROS production. Injured alveolar epithelial cells and macrophages thereby produce proinflammatory cytokines and chemokines to recruit immune cells into the alveoli. However, the infiltration of immune cells into the alveoli exacerbates the lung damage. Meanwhile, monocyte-derived macrophages and T-cells further undergo polarisation in response to various costimulants, potentially resulting in alveolar fibrosis, lung adenocarcinoma or gas exchange failure. EGFR: epidermal growth factor receptor; IFN-β: interferon-β; IL: interleukin; IM: interstitial macrophage; MΦ: macrophage; PM10: PM with a diameter ≤10 μm; Th: T-helper cell; TNF-α: tumour necrosis factor-α.

PM2.5 disrupts the integrity of the epithelial barrier and the cytokine expression, the first line of defence against pathogens

Due to the diameter of PMs, PM10–PM2.5 are typically trapped in the upper airways (nasal cavity, pharynx and larynx) to stimulate respiratory symptoms. In contrast, smaller particles (diameter ≤2.5 μm) are capable of penetrating more deeply into the lower respiratory tract (bronchioles and alveoli) or other organs by passing through the blood–air exchange system, thereby leading to severe disruptions [43]. Airway epithelial cells serve as the first line of defence against microbes and noxious stimuli by providing mucociliary clearance, secreting antimicrobial proteins and peptides, and interacting with specific immune cells to maintain homeostasis or facilitate immune reactions [44]. Exposure to PM2.5 causes ciliary disruption and increases mucus production [45, 46], which impairs mucociliary clearance and allows bacteria to adhere to and colonise the airway [47]. With ROS production induced by PM2.5, epithelial cells even reduce the expression of β-defensin-2, which is known as a skin antimicrobial peptide for the prevention of Gram-negative bacterial infections [48]. Meanwhile, epithelial cells, when stimulated by PM2.5, undergo mitochondrial fragmentation and dysfunction. This process leads to apoptosis through the abundant production of ROS or senescence and ferroptosis due to the downregulation of sirtuin 3, which is an essential factor in regulating mitochondrial metabolism and homeostasis [49]. Therefore, the changes in the integrity of the epithelial barrier and the function of epithelial cells generate a favourable environment for pathogen invasion [50]. Moreover, the production of excessive ROS mediated by PM2.5 enhances epithelial–mesenchymal transition, leading to carcinogenesis and fibrosis [51]. In addition to directly disrupting the integrity of epithelial barrier and their functions as the first line of defence against pathogens, PM2.5 stimulates the expression and secretions of proinflammatory cytokines including interleukin (IL)-6, IL-8, IL-1β and tumour necrosis factor-α (TNF-α) to accelerate lung injury and reduce the secretion of antiviral cytokine interferon-β (IFN-β) for protecting viral infection [52, 53]. Therefore, PM2.5 increases the prevalence, incidence and mortality of respiratory diseases.

PM2.5 alters the distribution of the alveolar macrophage population and its functions in the lung

Alveolar macrophages (AMs), including tissue-resident (TR) AMs (monocyte-derived AMs (Mo-AMs) and interstitial macrophages (IMs), are the major macrophages distributed in the lung [54]. IMs maintain lung homeostasis and prevent immune-mediated allergic airway inflammation [55]. In comparison to TR-AMs, Mo-AMs are more efficiently triggered by stimuli and respond to them more effectively [56]. Gangwar et al. [32] found that chronic exposure to PM2.5 increased the recruitment of monocytes from the bone marrow to the lung, followed by development and incorporation into the AM population. AMs in the lungs serve as the first line of defence for consuming inhaled particles and maintaining immune homeostasis in the lung [32]. However, exposure to PM2.5 enhances apoptosis and prevents the proliferation of TR-AMs, leading to a dramatic reduction in AM populations [32].

Macrophages differentiate into either classic (M1) or alternative (M2) macrophages after being activated by environmental stimulants [57]. Both M1 and M2 macrophages have distinct functions in modulating immune responses in the lung tissues [58]. M1 macrophages are capable of producing proinflammatory cytokines, such as IL-6, IL-12 and TNF-α, whereas M2 macrophages elicit contrasting anti-inflammatory responses (arginase-1, IL-10, CC chemokine ligand (CCL)17 or CCL22) for repairing damaged tissues, angiogenesis and regulating metabolism [58]. PM2.5 preferentially promotes the differentiation of Mo-AMs into M1 macrophages; however, it disrupts their ability to induce phagocytosis and autophagy [59, 60]. Interestingly, PM2.5 also increases M2 macrophage polarisation via TNF-α-induced protein 8-like 2 and an activated phosphoinositide 3-kinase/protein kinase B pathway, whereas heavy metals incorporated in PM2.5 trigger M2 macrophages to produce cytokines, mediating allergic responses [60, 61].

In addition to eliminating inhaled particles and secreting certain cytokines to maintain immune homeostasis, AMs in the lungs play a critical role in regulating the cytokines produced by T-cells, particularly in mediating the Th1/Th2 balance to eradicate pathogens [62]. However, PM2.5 exposure appears to disturb the Th1/Th2 balance. Both Ma et al. [63] and Piao et al. [64] found that PM2.5 exposure preferentially increases Th2/Th17 cytokines, but not Th1 cytokines, leading to enhanced cell infiltration and inflammatory responses in the respiratory tract.

To date, only a few studies have explored the influence of PM2.5 on IMs. Surprisingly, PM2.5 significantly increases IM population in the lung and elevates IL-1β secretion, which stimulates alveolar type II epithelial cells to express epidermal growth factor receptor for inducing tumorigenesis, leading to lung adenocarcinoma [65]. This indicates the potential effects of PM2.5 on promoting cancer progress.

PM2.5 stimulates inflammation cascades for recruiting immune cells to injured sites

Many pattern recognition receptors (PRRs), including Toll-like receptors (TLRs), C-type lectin receptors, retinoic acid-inducible gene-I-like receptors, nucleotide-binding domains and leucine-rich repeat-containing proteins (NLRs), are expressed in macrophages, dendritic cells, neutrophils and epithelial cells [66]. PRRs serve as immune sensors to recognise invading pathogens or environmental stimulants and initiate innate immunity. In particular, inflammasomes assemble to trigger caspase activities [67]. Among these PRRs, NLR family members are typically a part of the inflammasome [68]. Consumption of PM2.5 by macrophages or epithelial cells triggers the signalling cascade, leading to the formation of nucleotide-binding oligomerisation domain-like receptor family, pyrin domain containing protein 3 (NLRP3) inflammasome and selection of proinflammatory cytokines TNF-α and IL-1β, resulting in lung fibrosis [69]. Moreover, these pro-inflammatory cytokines recruit eosinophils and neutrophils, causing substantial lung damage [70]. Therefore, the depletion of NLRP3 in macrophages alleviates this phenomenon [71]. However, Tao et al. [72] showed that activation of the NLRP3 inflammasome was prevented during influenza A virus (IAV) infection after PM2.5 exposure. Further studies on the influence of PM2.5 on inflammasomes may be warranted to comprehensively analyse the impact of PM2.5 on respiratory immune functions and its correlation with microbial infectivity.

PM2.5 exacerbates bacterial infectivity in the respiratory system

Bacteria, identified as the predominant microorganisms associated with PM2.5, contribute significantly to the dissemination of respiratory diseases [73]. Epidemiological evidence suggests a positive correlation between PM2.5 exposure and elevated susceptibility to respiratory pathogen infections [73, 74]. PM2.5 negatively impacts macrophage functions, such as phagocytosis and nitric oxide production, ultimately exacerbating Streptococcus pneumoniae invasion [59]. This effect was also observed in vivo by Shears et al. [75], who found increased pneumococcal loads in the lungs and the development of invasive pneumococcal disease following exposure to diesel exhaust particles. Exposure to air pollution elevates the susceptibility to Staphylococcus aureus infection in the respiratory tracts of rats [76]. This heightened vulnerability is attributed to the reduction in natural killer cells, which subsequently suppress phagocytosis activity [76]. Furthermore, PM2.5, synergised with Pseudomonas aeruginosa to impede alveolar macrophage function, causes more severe respiratory system injuries via a process closely related to the activation of the mammalian target of rapamycin signalling pathway [77].

Some researchers believe that PM2.5 can enhance inflammation in immune cells. Consequently, increased inflammation after bacterial invasion can lead to severe infections (table 1). PM2.5 has been implicated in the disturbance of the secretion of proinflammatory cytokines and iron metabolites, accelerating the growth of Mycobacterium tuberculosis and its transformation into an invasive mycobacterium [78]. Moreovcer, significant pathological damage was observed in the lung tissues of mice co-stimulated by PM2.5 and Pseudomonas aeruginosa, resulting from the increased expression levels of IL-6, IL-8 and TNF-α via the NF-κB pathway [79].

TABLE 1 Experimental models for investigating the influence of particulate matter with a diameter ≤2.5 μm (PM2.5) on bacterial infections

Experimental platform	Pathogen	Immune response	Reference	
PM2.5 suppresses immune response and exacerbates bacterial infection	
 Sprague–Dawley rats	Listeria monocytogenes	Exposure to diesel exhaust particles decreased the production of macrophage-derived antimicrobial oxidants in response to Listeria	[113]	
 BALB/c mice	Streptococcus pneumoniae	Soluble components of concentrated ambient particles inhibit the internalisation of Streptococcus pneumoniae by macrophages	[114]	
 A549 cells	Streptococcus pneumoniae	PM2.5 stimulates Streptococcus pneumoniae to adhere to respiratory epithelial cells	[115]	
 Sprague–Dawley rats	Klebsiella pneumoniae	PM2.5 impairs the bronchial ciliary system and the interaction of cytokines, increasing susceptibility to bacterial infection	[80]	
 Wistar rats	Staphylococcus aureus	PM2.5 downregulates macrophage phagocytosis and reduces pulmonary natural killer cells	[76]	
 Clinical study (a systemic review)	Mycobacterium tuberculosis	PM2.5 suppresses immune defence, increasing an individual's susceptibility to development of active TB and TB-related mortality	[78]	
 CD1, C57BL/6 and BALB/c mice	Streptococcus pneumoniae	PM loading of macrophages is associated with reduced phagocytic killing activity and promotes inflammation in the context of bacterial challenge	[75]	
 RAW 264.7 cells and BALB/c mice	Streptococcus pneumoniae	PM2.5 impedes the macrophage function to exacerbate bacterial infection	[59]	
 C57BL/6 mice	Pseudomonas aeruginosa	PM2.5 and Pseudomonas aeruginosa synergistically dampen alveolar macrophage function and induce inflammation through the mTOR pathway	[77]	
PM2.5 enhances immune response and promotes inflammation	
 Clinical study (a systemic review)	Mycoplasma pneumoniae	The induction of oxidative stress mechanisms and the modulation of the host immune system are attributed to the interaction between PM2.5-associated metal complexes and Mycoplasma pneumoniae This interaction is assumed to occur through the TLRs and/or NF-κB pathway	[116]	
 RAW 264.7 cells and BALB/c mice	Pseudomonas aeruginosa	Co-stimulation with PM2.5 and Pseudomonas aeruginosa increases the expression of IL-8, IL-6 and TNF-α, leading to severe inflammation	[79]	
IL: interleukin; mTOR: mammalian target of rapamycin; TB: tuberculosis; TLR: Toll-like receptor; TNF-α: tumour necrosis factor-α.

As indicated earlier, PM2.5 compromises bacterial clearance by disrupting immune responses or inducing severe inflammation, ultimately leading to tissue damage [75, 80, 81]. Notably, exposure to PM2.5 has a pronounced impact on vulnerable populations, including children, the elderly and individuals with underlying or potential pulmonary diseases [82]. Exposure to PM2.5 elevates the potential risk of initial acquisition of methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa in young children with cystic fibrosis [83]. PM2.5 poses a significant challenge in developed countries, with an increasing number of pathogens identified as those that cause diseases following exposure. However, a gap remains in robust research on molecular mechanisms and effective treatment strategies.

PM2.5 alters microbiota composition in the respiratory tract

The microbiome has been identified as a critical player in defending the respiratory tract against pathogen colonisation and in influencing the development of respiratory structures and immunity. Microbial dysbiosis disrupts the host homeostasis and promotes disease progression. Notably, alterations in the microbiota can directly stimulate pulmonary inflammation and oxidative stress in response to PM2.5 [84]. Furthermore, exposure to PM2.5 is related to a decrease in lung microbiota diversity, enhanced susceptibility to pneumococcal infection and exacerbated lung pathogenesis [85]. Additionally, exposure to PM2.5 correlates with changes in the respiratory microbiome, affecting both normal flora and potential pathogens, potentially compromising pulmonary function in affected individuals [31]. Remarkably, antibiotic treatment alleviates pulmonary inflammation and oxidative damage in mice by promoting microbiota diversity, decreasing the abundance of Proteobacteria and increasing the abundance of Bacteroidota [84]. As the microbiome is established during childhood, the determinants of lung bacterial colonisation in children are associated with the mode of delivery and feeding type [86]. This evidence suggests that air pollution is associated with respiratory diseases in children [87]. Furthermore, various sources of PMs affect microbial profiles in different ways. These results contribute to a better understanding of the impact of air pollution on organismal microbiota and underscore the importance of safeguarding the health of the respiratory system.

PM2.5 impedes immune response against viral infections

Exposure to particulate pollution is known to affect the respiratory system and damage pulmonary function (table 2) [70, 88–90]. Exposure to air pollution also critically influences the ability of viruses to infect cells to cause severe infection [91, 92]. For instance, PM2.5 promotes the entry of severe acute respiratory syndrome coronavirus 2 into host cells by enhancing the expression of angiotensin-converting enzyme 2 (ACE2) and transmembrane protease serine 2 (TMPRSS2) in human alveolar cells [93]. This increase in viral entry contributes to the severity of coronavirus disease 2019, placing an additional burden on medical care systems during the pandemic [94]. PM2.5 promotes IAV infection by enhancing the expression of intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1) [95, 96]. Additionally, ACE2 and TMPRSS2 are critical for wound healing and inflammation [97]; whereas ICAM-1 and VCAM-1 are required for the recruitment of leukocytes to inflammatory lesions [98]. The promotion of the expression of these molecules by PM2.5 may enhance inflammatory responses that are required for viral clearance.

TABLE 2 Immune responses induced by particulate matter with a diameter ≤2.5 μm (PM2.5)

Experimental platform	PM2.5 exposure time #	Immune response	Reference	
Immune responses enhanced by PM2.5	
 Peritoneal macrophages isolated from C57BL/6 mice	Short-term	PM2.5 induces polarisation of macrophage through induction of ROS	[105]	
 Human umbilical vein cell line, EA.hy926	Short-term	PM2.5 induces ERK/AKT/NF-κB signalling pathway and results in increased ICAM-1 and VCAM-1 expression	[96]	
 Human bronchial epithelial cells, 16HBE cells	Short-term	PM2.5 induces the NLRP3/caspase-1 pathway and results in cell-secreted inflammatory cytokines	[70]	
 Murine model	Short-term	PM2.5 increases ACE2 and TMPRSS2 expression	[93]	
 BALB/c mice	Long-term
(6 days)	PM2.5 increases ACE2, COX-2 and HO-1 expression in several organs, including lung, heart, liver and brain	[103]	
 BALB/c mice	Long-term
(14 days)	PM2.5 induces the NLRP3/caspase-1 pathway and results in mice lung inflammatory	[70]	
 BALB/c mice	Long-term
(90 days)	PM2.5 activates the Notch signalling pathway and results in increased Th1/Th2 and Th17/Treg cells	[108]	
 C57BL/6 mice	Long-term
(12 weeks)	PM2.5 regulates TNF-α and IL-6, leading to lung damage	[117]	
 Human experiment: traffic policemen	Long-term
(4 months)	PM2.5 elevates hsCRP, IgM, IgG and IgE	[106]	
Immune responses reduced by PM2.5	
 Human experiment: traffic policemen	Long-term
(4 months)	PM2.5 decreases the expression of IgA and CD8+ T-cells	[106]	
#: Short-term exposure: exposure to PM2.5 within 24 h; long-term exposure: exposure to PM2.5 for more than 24 h. ACE2: angiotensin converting enzyme 2; AKT: protein kinase B; COX-2: cyclooxygenase 2; ERK: extracellular signal-regulated kinase; HO-1: haem oxygenase 1; hsCRP: highly sensitive C-reactive protein; ICAM-1: intercellular adhesion molecule-1; IL: interleukin; NLRP3: nucleotide-binding oligomerisation domain-like receptor family, pyrin domain containing protein 3; ROS: reactive oxygen species; Th: T-helper cell; TMPRSS2: transmembrane protease serine 2; TNF-α: tumour necrosis factor-α; Treg: regulatory T-cell; VCAM1: vascular cell adhesion molecule-1.

Exposure to PM2.5 and simultaneous infection by IAV or coxsackievirus B3 significantly enhances the expression of proinflammatory cytokines, such as IL-6, TNF-α and transforming growth factor (TGF)-β, in both cell and mouse models [99, 100]. The induction of the expression of these proinflammatory cytokines leads to hyperinflammation and, in some cases, triggers a cytokine storm, resulting in severe symptoms and increased mortality [101, 102]. Botto et al. [103] showed that PM2.5 activates cyclooxygenase 2 to enhance the expression of proinflammatory lipids, which mediate widespread inflammation and tissue damage, exacerbating cytokine storms. Additionally, exposure to PM2.5 leads to the overproduction of ROS in macrophages [95, 104]. When the production of ROS is inhibited, the expression of granulocyte−macrophage colony-stimulating factor, IL-6 and TNF-α is reduced, suggesting that the release of inflammatory cytokines induced by PM2.5 depends on ROS [105]. Furthermore, PM2.5 exposure has been linked to the proinflammatory M1 macrophage polarisation, which further promotes the release of cytokines, such as IL-6, TNF-α, TGF-β and IL-18 [105].

Apart from affecting the innate immune response, PM2.5 exposure influences adaptive immunity. PM2.5 exposure elevates highly sensitive C-reactive protein, IgM, IgG, IgE and CD4+Foxp3+ cells (regulatory T-cells (Tregs)) and decreases the expression of IgA and production of CD8+ T-cells [99, 106]. These changes in adaptive immunity increase inflammatory cytokine production, promoting cytokine storms and allergic reactions [107]. PM2.5 exposure elevates Th1/Th2 and Th17/Treg cell ratios in both healthy mice and mice with COPD via the Notch signalling pathway [108]. This T-cell imbalance is associated with an increased production of pro-inflammatory cytokines, leading to inflammatory disorders and exacerbation of the immune response [109]. Moreover, prolonged exposure to PM2.5 increases the infiltration of inflammatory cells, leading to chronic inflammatory responses and pulmonary fibrosis [70, 88, 89], which increases the risk of acute respiratory distress syndrome [36] and mortality [110]. These studies suggest that PM2.5 accelerates the progression of severe cytokine storms during respiratory viral infections (table 3).

TABLE 3 Immune responses and potential effects induced by particulate matter with a diameter ≤2.5 μm (PM2.5) on viral infections

Experimental platform	PM2.5 exposure time #	Pathogen	Immune response	Reference	
Immune responses/effects enhanced by PM2.5 on virus infection	
 BALB/c mice	Short-term	Coxsackievirus B3	PM2.5 enhances Treg cell and IL-6, TNF-α and TGF-β	[99]	
 Murine model	Short-term	Influenza A virus	PM2.5 increases secreted IL-6, IL-1β and IFN-β in the lungs	[100]	
 C57BL/6	long-term	SARS-CoV-2	PM2.5 increases TNF-α, TGF-β1 and IL-6 in the lungs	[118]	
 BABL/c mice	Long-term
(>1 week)	Influenza A virus	PM2.5 drives influenza A virus deep into the lower respiratory tract and distant organs	[119]	
Immune responses reduced by PM2.5 on virus infection	
 Macrophage isolated from  C57BL/6 mice	Short-term	Influenza A virus	PM2.5 decreases IL-1β and IFN-β production	[72]	
 A549 cells	Short-term	Vesicular stomatitis virus	PM2.5 degrades p-IRF3 via ubiquitination, resulting in decreased IFN-β levels and promoting viral replication	[111]	
 C57BL/6 mice	Long-term
(3 days)	Influenza A virus	PM2.5 decreases IL-1β and IFN-β production	[72]	
 Murine model	Long-term
(2 weeks)	Influenza A virus	PM2.5 suppresses influenza A-induced secreted IL-6, IL-1β and IFN-β in the lungs	[100]	
#: Short-term exposure: exposure to PM2.5 within 24 h; long-term exposure: exposure to PM2.5 for more than 24 h. IFN-β: interferon-β; IL: interleukin; p-IRF3: phosphorylated interferon regulatory factor 3; SARS-CoV-2: severe acute respiratory syndrome coronavirus 2; TGF: transforming growth factor; TNF-α: tumour necrosis factor-α; Treg: regulatory T-cell.

Exposure to PM2.5 is also linked to the suppression of the interferon type-1 pathway, potentially rendering the immune system less effective against viral infection [72, 100, 111]. Various studies have identified distinct pathways through which PM2.5 exerts this effect. For instance, PM2.5 exposure increases 2,3,7,8-tetrachlorodibenzo-p-dioxin inducible poly(ADP-ribose) polymerase expression by activating the aryl hydrocarbon receptor, resulting in the suppression of the NLRP3 inflammasome (responsible for the expression of IL-1β and IL-18) and IFN-β expression [72]. These effects can potentially weaken the immune system, rendering the host more susceptible to viral infections [112]. Additionally, PM2.5 degrades phosphorylated interferon regulatory factor 3 via ubiquitination, resulting in decreased IFN-β levels and promoting the replication of the vesicular stomatitis virus (VSV) [111]. Meanwhile, Ma et al. [100] showed that prolonged exposure to PM2.5 for more than 7 days leads to the inhibition of the secretion of inflammatory cytokines, IFN-β and IL-6 in pulmonary macrophages via downregulation of lysine demethylase 6A (Kdm6a) expression, which is required to regulate the transcription of IL-6 and IFN-β. Tao et al. [72] also observed that exposure to PM2.5 for 3 and 6 days suppresses the expression of IL1-β, either in a single-exposure scenario or in the presence of H1N1/PR8 infection. These studies suggest that prolonged PM2.5 exposure suppresses, instead of inducing, the expression of inflammatory cytokines. However, the specific mechanisms and timelines underlying this phenomenon require further investigation.

The inconsistency of the effects of PM2.5, including the duration and experimental models used for PM2.5, on viral infection and inflammation may be multifactorial. Differences in the pathogenic mechanisms induced by viral infections and other factors, such as chronic diseases caused by inflammation and vaccination, may also contribute to varying outcomes. Age, sex and genetic variations may influence inflammatory responses. However, the precise mechanisms underlying this phenomenon remain unclear and require further investigation. Ma et al. [100] provided a more robust mouse model to monitor immune responses and inflammatory injuries after short-term (within 24 h) and long-term exposure to PM2.5, followed by IAV infection. Their results concluded that PM2.5 exposure for more than 1 week significantly reduced the secretion of inflammatory factors and downstream immune-stimulated gene responses, leading to decreased immunity for clearance of IAV and lung injuries.

Conclusions and perspectives

The relationships between PM2.5 and health problems are well-documented. PM2.5 can be inhaled deeply into the lungs and potentially transport a variety of pollutants, including pathogens. Current studies rely predominantly on cell-based assays or animal models, with limited emphasis on in-depth clinical research in humans. Although these experimental approaches provide valuable insights, their application to human health remains limited. Additionally, there are a limited number of studies investigating the potential mechanism through which PM2.5 affects the microbiota composition in the human respiratory tract. Furthermore, extensive exploration of the long-term immune responses associated with microbiota dysbiosis due to PM2.5 exposure is needed. The important microbial metabolites involved in PM2.5, which exacerbate pathogen-induced pulmonary pathogenesis, must be studied. Understanding the potential limitations of the current studies and promoting more comprehensive clinical investigations are crucial for filling the gap between experimental findings and practical applications in humans.

Points for clinical practice

Clinicians should be aware of the exacerbating effects of PM2.5 on respiratory infections, particularly in vulnerable populations such as children, the elderly and individuals with underlying respiratory conditions.

It is important to continuously monitor air quality and advise patients on minimising exposure to PM2.5, particularly during high pollution periods.

Integrating information about air pollution and its health impacts into patient education can aid in managing and preventing respiratory condition exacerbations.

Questions for future research

What are the long-term effects of chronic PM2.5 exposure on the human respiratory immune system?

What are the underlying molecular mechanisms that link PM2.5 exposure to increased susceptibility to respiratory infections?

Can interventions targeting the immune response significantly mitigate the adverse health effects of PM2.5 exposure, thereby improving public health outcomes?

Acknowledgements

The authors thank the editor and reviewers for their editorial assistance and valuable comments.

Provenance: Submitted article, peer reviewed.

Author Contributions: Conception and design of this work: Y-F. Chiu, C-H. Lai and M-L. Kuo. Writing the manuscript: J. Ma, Y-F. Chiu, C-N. Chuang, C-C. Kao, C-Y. Chen, C-H. Lai and M-L. Kuo. Final approval: all authors.

Conflict of interest: All authors have nothing to disclose.

Support statement: This research was supported by the Taiwan National Science and Technology Council (112-2320-B-182-033 and 112-2320-B-182-042-MY3), Chang Gung Medical Research Program (CMRPD1M0871, BMRPF14, CMRPD1J0021-3, CMRPD1M0261-3), and Research Center for Emerging Viral Infections from the Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Taiwan Ministry of Education. Funding information for this article has been deposited with the Crossref Funder Registry.
==== Refs
References

1 Thangavel P, Park D, Lee YC. Recent insights into particulate matter (PM2.5)-mediated toxicity in humans: an overview. Int J Environ Res Public Health 2022; 19 : 7511. doi:10.3390/ijerph19127511 35742761
2 Lee KK, Bing R, Kiang J, et al. Adverse health effects associated with household air pollution: a systematic review, meta-analysis, and burden estimation study. Lancet Glob Health 2020; 8 : e1427–e1434. doi:10.1016/S2214-109X(20)30343-0 33069303
3 Dhimal M, Chirico F, Bista B, et al. Impact of air pollution on global burden of disease in 2019. Processes 2021; 9 : 1719. doi:10.3390/pr9101719
4 World Health Organization . Air Quality Guidelines – Update 2021. Copenhagen, Denmark, WHO Regional Office for Europe, 2021.
5 Andersen ZJ, Gehring U, De Matteis S, et al. Clean air for healthy lungs – an urgent call to action: European Respiratory Society position on the launch of the WHO 2021 air quality guidelines. Eur Respir J 2021; 58 : 2102447. doi:10.1183/13993003.02447-2021 34561297
6 Costa S, Ferreira J, Silveira C, et al. Integrating health on air quality assessment—review report on health risks of two major European outdoor air pollutants: PM and NO2. J Toxicol Environ Health B Crit Rev 2014; 17 : 307–340. doi:10.1080/10937404.2014.946164 25333993
7 Fuzzi S, Baltensperger U, Carslaw KS, et al. Particulate matter, air quality and climate: lessons learned and future needs. Atmos Chem Phys 2015; 15 : 8217–8299. doi:10.5194/acp-15-8217-2015
8 Wise J. Pollution: 90% of world population breathes air that exceeds WHO targets on particulate matter. BMJ 2023; 380 : 615. doi:10.1136/bmj.p615 36921959
9 Southerland VA, Brauer M, Mohegh A, et al. Global urban temporal trends in fine particulate matter (PM2.5) and attributable health burdens: estimates from global datasets. Lancet Planet Health 2022; 6 : e139–e146. doi:10.1016/S2542-5196(21)00350-8 34998505
10 Chowdhury S, Pillarisetti A, Oberholzer A, et al. A global review of the state of the evidence of household air pollution's contribution to ambient fine particulate matter and their related health impacts. Environ Int 2023; 173 : 107835. doi:10.1016/j.envint.2023.107835 36857905
11 Awe YA, Larsen BK, Sanchez-Triana E. The Global Health Cost of PM 2.5 Air Pollution: A Case for Action Beyond 2021. Washington, World Bank Group, 2022. http://documents.worldbank.org/curated/en/455211643691938459/The-Global-Health-Cost-of-PM-2-5-Air-Pollution-A-Case-for-Action-Beyond-2021
12 Rentschler J, Leonova N. Global air pollution exposure and poverty. Nat Commun 2023; 14 : 4432. doi:10.1038/s41467-023-39797-4 37481598
13 Wisnivesky J, De-Torres JP. The global burden of pulmonary diseases: most prevalent problems and opportunities for improvement. Ann Glob Health 2019; 85 : 1. doi 10.5334/aogh.2411 30741502
14 World Health Organization. Global health estimates 2020: deaths by cause, age, sex, by country and by region, 2000–2019. Date last updated: December 2020. Date last accessed: 23 July 2024. www.who.int/data/gho/data/themes/mortality-and-global-health-estimates/ghe-leading-causes-of-death
15 Halpin DMG, Vogelmeier CF, Agustí AJ, et al. Lung health for all: chronic obstructive lung disease and world lung day 2022. Am J Respir Crit Care Med 2022; 206 : 669–671. doi:10.1164/rccm.202207-1407ED 36112775
16 Croft DP, Zhang W, Lin S, et al. The association between respiratory infection and air pollution in the setting of air quality policy and economic change. Ann Am Thorac Soc 2019; 16 : 321–330. doi:10.1513/AnnalsATS.201810-691OC 30398895
17 Ali N, Islam F. The effects of air pollution on COVID-19 infection and mortality–a review on recent evidence. Front Public Health 2020; 8 : 580057. doi:10.3389/fpubh.2020.580057 33324598
18 Shang Y, Sun Q. Particulate air pollution: major research methods and applications in animal models. Environ Dis 2018; 3 : 57–62. doi:10.4103/ed.ed_16_18 31549002
19 Daellenbach KR, Uzu G, Jiang J, et al. Sources of particulate-matter air pollution and its oxidative potential in Europe. Nature 2020; 587 : 414–419. doi:10.1038/s41586-020-2902-8 33208962
20 Kwon HS, Ryu MH, Carlsten C. Ultrafine particles: unique physicochemical properties relevant to health and disease. Exp Mol Med 2020; 52 : 318–328. doi:10.1038/s12276-020-0405-1 32203103
21 Li F, Gu J, Xin J, et al. Characteristics of chemical profile, sources and PAH toxicity of PM2.5 in Beijing in autumn–winter transit season with regard to domestic heating, pollution control measures and meteorology. Chemosphere 2021; 276 : 130143. doi:10.1016/j.chemosphere.2021.130143 33743423
22 Kawashima H, Yoshida O, Joy KS, et al. Sources identification of ammonium in PM2.5 during monsoon season in Dhaka, Bangladesh. Sci Total Environ 2022; 838 : 156433. doi:10.1016/j.scitotenv.2022.156433 35660591
23 Masri S, Kang CM, Koutrakis P. Composition and sources of fine and coarse particles collected during 2002–2010 in Boston, MA. J Air Waste Manag Assoc 2015; 65 : 287–297. doi:10.1080/10962247.2014.982307 25947125
24 Kumar P, Rivas I, Singh AP, et al. Dynamics of coarse and fine particle exposure in transport microenvironments. NPJ Clim Atmos Sci 2018; 1 : 11. doi:10.1038/s41612-018-0023-y
25 Pitchford M, Maim W, Schichtel B, et al. Revised algorithm for estimating light extinction from IMPROVE particle speciation data. J Air Waste Manag Assoc 2007; 57 : 1326–1336. doi:10.3155/1047-3289.57.11.1326 18069456
26 Bawase M, Sathe Y, Khandaskar H, et al. Chemical composition and source attribution of PM2.5 and PM10 in Delhi-National Capital Region (NCR) of India: results from an extensive seasonal campaign. J Atmos Chem 2021; 78 : 35–58. doi:10.1007/s10874-020-09412-7
27 Zheng Y, Miao R, Zhang Q, et al. Secondary formation of submicron and supermicron organic and inorganic aerosols in a highly polluted urban area. J Geophys Res Atmos 2023; 128 : e2022JD037865. doi:10.1029/2022JD037865
28 Perrone MR, Bertoli I, Romano S, et al. PM2.5 and PM10 oxidative potential at a central Mediterranean site: contrasts between dithiothreitol- and ascorbic acid-measured values in relation with particle size and chemical composition. Atmos Environ 2019; 210 : 143–155. doi:10.1016/j.atmosenv.2019.04.047
29 Fussell JC, Kelly FJ. Mechanisms underlying the health effects of desert sand dust. Environ Int 2021; 157 : 106790. doi:10.1016/j.envint.2021.106790 34333291
30 Samet JM. Do coarse mass particles increase daily mortality? New findings from a multi-country, multi-city study. Am J Respir Crit Care Med 2022; 206 : 932–933. doi:10.1164/rccm.202206-1178ED 35737941
31 Panumasvivat J, Pratchayasakul W, Sapbamrer R, et al. The possible role of particulate matter on the respiratory microbiome: evidence from in vivo to clinical studies. Arch Toxicol 2023; 97 : 913–930. doi:10.1007/s00204-023-03452-0 36781433
32 Gangwar RS, Vinayachandran V, Rengasamy P, et al. Differential contribution of bone marrow-derived infiltrating monocytes and resident macrophages to persistent lung inflammation in chronic air pollution exposure. Sci Rep 2020; 10 : 14348. doi:10.1038/s41598-020-71144-1 32873817
33 Borgie M, Ledoux F, Verdin A, et al. Genotoxic and epigenotoxic effects of fine particulate matter from rural and urban sites in Lebanon on human bronchial epithelial cells. Environ Res 2015; 136 : 352–362. doi:10.1016/j.envres.2014.10.010 25460656
34 Rauf AU, Mallongi A, Lee K, et al. Potentially toxic element levels in atmospheric particulates and health risk estimation around industrial areas of Maros, Indonesia. Toxics 2021; 9 : 328. doi:10.3390/toxics9120328 34941762
35 Alves C, Evtyugina M, Vicente E, et al. PM2.5 chemical composition and health risks by inhalation near a chemical complex. J Environ Sci 2023; 124 : 860–874. doi:10.1016/j.jes.2022.02.013
36 Hussar E, Richards S, Lin ZQ, et al. Human health risk assessment of 16 priority polycyclic aromatic hydrocarbons in soils of Chattanooga, Tennessee, USA. Water Air Soil Pollut 2012; 223 : 5535–5548. doi:10.1007/s11270-012-1265-7 23243323
37 Choi H, Harrison R, Komulainen H, et al. Chapter 6: Polycyclic aromatic hydrocarbons. In: World Health Organization, ed. WHO Guidelines for Indoor Air Quality: Selected Pollutants. Geneva, World Health Organization, 2010.
38 Bukowska B, Mokra K, Michalowicz J. Benzo[a]pyrene-environmental occurrence, human exposure, and mechanisms of toxicity. Int J Mol Sci 2022; 23 : 6348. doi:10.3390/ijms23116348 35683027
39 Wilk A, Waligorski P, Lassak A, et al. Polycyclic aromatic hydrocarbons-induced ROS accumulation enhances mutagenic potential of T-antigen from human polyomavirus JC. J Cell Physiol 2013; 228 : 2127–2138. doi:10.1002/jcp.24375 23558788
40 Moorthy B, Chu C, Carlin DJ. Polycyclic aromatic hydrocarbons: from metabolism to lung cancer. Toxicol Sci 2015; 145 : 5–15. doi:10.1093/toxsci/kfv040 25911656
41 Hsieh CY, Jung CR, Lin CY, et al. Combined exposure to heavy metals in PM2.5 and pediatric asthma. J Allergy Clin Immunol 2021; 147 : 2171–2180. doi:10.1016/j.jaci.2020.12.634 33378689
42 Zheng Y, Chen S, Chen Y, et al. Association between PM2.5-bound metals and pediatric respiratory health in Guangzhou: an ecological study investigating source, health risk, and effect. Front Public Health 2023; 11 : 1137933. doi:10.3389/fpubh.2023.1137933 36969623
43 Xing YF, Xu YH, Shi MH, et al. The impact of PM2.5 on the human respiratory system. J Thorac Dis 2016; 8 : E69–E74. doi:10.3978/j.issn.2072-1439.2016.01.19 26904255
44 Iwasaki A, Foxman EF, Molony RD. Early local immune defences in the respiratory tract. Nat Rev Immunol 2017; 17 : 7–20. doi:10.1038/nri.2016.117 27890913
45 He F, Liao B, Pu J, et al. Exposure to ambient particulate matter induced COPD in a rat model and a description of the underlying mechanism. Sci Rep 2017; 7 : 45666. doi:10.1038/srep45666 28361885
46 Zhao R, Guo Z, Dong W, et al. Effects of PM2.5 on mucus secretion and tissue remodeling in a rabbit model of chronic rhinosinusitis. Int Forum Allergy Rhinol 2018; 8 : 1349–1355. doi:10.1002/alr.22182 29999600
47 Livraghi A, Randell SH. Cystic fibrosis and other respiratory diseases of impaired mucus clearance. Toxicol Pathol 2007; 35 : 116–129. doi:10.1080/01926230601060025 17325980
48 Chen X, Liu J, Zhou J, et al. Urban particulate matter (PM) suppresses airway antibacterial defence. Respir Res 2018; 19 : 5. doi:10.1186/s12931-017-0700-0 29310642
49 Li N, Xiong R, Li G, et al. PM2.5 contributed to pulmonary epithelial senescence and ferroptosis by regulating USP3–SIRT3–P53 axis. Free Radic Biol Med 2023; 205 : 291–304. doi:10.1016/j.freeradbiomed.2023.06.017 37348684
50 Aghapour M, Ubags ND, Bruder D, et al. Role of air pollutants in airway epithelial barrier dysfunction in asthma and COPD. Eur Respir Rev 2022; 31 : 210112. doi:10.1183/16000617.0112-2021 35321933
51 Xu Z, Ding W, Deng X. PM2.5, fine particulate matter: a novel player in the epithelial–mesenchymal transition? Front Physiol 2019; 10 : 1404. doi:10.3389/fphys.2019.01404 31849690
52 Zou W, Wang X, Hong W, et al. PM2.5 induces the expression of inflammatory cytokines via the Wnt5a/Ror2 pathway in human bronchial epithelial cells. Int J Chron Obstruct Pulmon Dis 2020; 15 : 2653–2662. doi:10.2147/COPD.S270762 33122903
53 Wang Y, Zhang R, Yang F, et al. Potential mechanisms mediating PM2.5-induced alterations of H3N2 influenza virus infection and cytokine production in human bronchial epithelial cells. Ecotoxicol Environ Saf 2023; 259 : 115069. doi:10.1016/j.ecoenv.2023.115069 37244199
54 Hou F, Xiao K, Tang L, et al. Diversity of macrophages in lung homeostasis and diseases. Front Immunol 2021; 12 : 753940. doi:10.3389/fimmu.2021.753940 34630433
55 Schyns J, Bureau F, Marichal T. Lung interstitial macrophages: past, present, and future. J Immunol Res 2018; 2018 : 5160794. doi:10.1155/2018/5160794 29854841
56 Kulikauskaite J, Wack A. Teaching old dogs new tricks? The plasticity of lung alveolar macrophage subsets. Trends Immunol 2020; 41 : 864–877. doi:10.1016/j.it.2020.08.008 32896485
57 Arora S, Dev K, Agarwal B, et al. Macrophages: their role, activation and polarization in pulmonary diseases. Immunobiology 2018; 223 : 383–396. doi:10.1016/j.imbio.2017.11.001 29146235
58 Mills CD. M1 and M2 macrophages: oracles of health and disease. Crit Rev Immunol 2012; 32 : 463–488. doi:10.1615/CritRevImmunol.v32.i6.10 23428224
59 Chen YW, Huang MZ, Chen CL, et al. PM2.5 impairs macrophage functions to exacerbate pneumococcus-induced pulmonary pathogenesis. Part Fibre Toxicol 2020; 17 : 37. doi:10.1186/s12989-020-00362-2 32753046
60 Yunna C, Mengru H, Lei W, et al. Macrophage M1/M2 polarization. Eur J Pharmacol 2020; 877 : 173090. doi:10.1016/j.ejphar.2020.173090 32234529
61 Liu H, Nie H, Lai W, et al. Different exposure modes of PM2.5 induces bronchial asthma and fibrosis in male rats through macrophage activation and immune imbalance induced by TIPE2 methylation. Ecotoxicol Environ Saf 2022; 247 : 114200. doi:10.1016/j.ecoenv.2022.114200 36274320
62 Hu G, Christman JW. Editorial: alveolar macrophages in lung inflammation and resolution. Front Immunol 2019; 10 : 2275. doi:10.3389/fimmu.2019.02275 31616438
63 Ma QY, Huang DY, Zhang HJ, et al. Exposure to particulate matter 2.5 (PM2.5) induced macrophage-dependent inflammation, characterized by increased Th1/Th17 cytokine secretion and cytotoxicity. Int Immunopharmacol 2017; 50 : 139–145. doi:10.1016/j.intimp.2017.06.019 28654841
64 Piao CH, Fan Y, Nguyen TV, et al. PM2.5 exposure regulates Th1/Th2/Th17 cytokine production through NF- κB signaling in combined allergic rhinitis and asthma syndrome. Int Immunopharmacol 2023; 119 : 110254. doi:10.1016/j.intimp.2023.110254 37163921
65 Han SC, Wang GZ, Zhou GB. Air pollution, EGFR mutation, and cancer initiation. Cell Rep Med 2023; 4 : 101046. doi:10.1016/j.xcrm.2023.101046 37196632
66 Franchi L, Warner N, Viani K, et al. Function of Nod-like receptors in microbial recognition and host defense. Immunol Rev 2009; 227 : 106–128. doi:10.1111/j.1600-065X.2008.00734.x 19120480
67 Kanneganti TD. The inflammasome: firing up innate immunity. Immunol Rev 2015; 265 : 1–5. doi:10.1111/imr.12297 25879279
68 Davis BK, Wen H, Ting JP. The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu Rev Immunol 2011; 29 : 707–735. doi:10.1146/annurev-immunol-031210-101405 21219188
69 Cao W, Wang X, Li J, et al. NLRP3 inflammasome activation determines the fibrogenic potential of PM2.5 air pollution particles in the lung. J Environ Sci 2022; 111 : 429–441. doi:10.1016/j.jes.2021.04.021
70 Jia H, Liu Y, Guo D, et al. PM2.5-induced pulmonary inflammation via activating of the NLRP3/caspase-1 signaling pathway. Environ Toxicol 2021; 36 : 298–307. doi:10.1002/tox.23035 32996690
71 Xiong R, Jiang W, Li N, et al. PM2.5-induced lung injury is attenuated in macrophage-specific NLRP3 deficient mice. Ecotoxicol Environ Saf 2021; 221 : 112433. doi:10.1016/j.ecoenv.2021.112433 34146983
72 Tao RJ, Cao WJ, Li MH, et al. PM2.5 compromises antiviral immunity in influenza infection by inhibiting activation of NLRP3 inflammasome and expression of interferon-β. Mol Immunol 2020; 125 : 178–186. doi:10.1016/j.molimm.2020.07.001 32717666
73 Zhang S, Huo X, Zhang Y, et al. The association of PM2.5 with airway innate antimicrobial activities of salivary agglutinin and surfactant protein D. Chemosphere 2019; 226 : 915–923. doi:10.1016/j.chemosphere.2019.04.032 31509921
74 Arredouani MS, Yang Z, Imrich A, et al. The macrophage scavenger receptor SR-AI/II and lung defense against pneumococci and particles. Am J Respir Cell Mol Biol 2006; 35 : 474–478. doi:10.1165/rcmb.2006-0128OC 16675784
75 Shears RK, Jacques LC, Naylor G, et al. Exposure to diesel exhaust particles increases susceptibility to invasive pneumococcal disease. J Allergy Clin Immunol 2020; 145 : 1272–1284. doi:10.1016/j.jaci.2019.11.039 31983527
76 Zhao H, Li W, Gao Y, et al. Exposure to particular matter increases susceptibility to respiratory Staphylococcus aureus infection in rats via reducing pulmonary natural killer cells. Toxicology 2014; 325 : 180–188. doi:10.1016/j.tox.2014.09.006 25220797
77 Zhang J, Liu C, Zhao G, et al. PM2.5 synergizes with Pseudomonas aeruginosa to suppress alveolar macrophage function in mice through the mTOR pathway. Front Pharmacol 2022; 13 : 924242. doi:10.3389/fphar.2022.924242 35800443
78 Popovic I, Soares Magalhaes RJ, Ge E, et al. A systematic literature review and critical appraisal of epidemiological studies on outdoor air pollution and tuberculosis outcomes. Environ Res 2019; 170 : 33–45. doi:10.1016/j.envres.2018.12.011 30557690
79 Li M, Wei X, Li Y, et al. PM2.5 in poultry houses synergizes with Pseudomonas aeruginosa to aggravate lung inflammation in mice through the NF-κB pathway. J Vet Sci 2020; 21 : e46. doi:10.4142/jvs.2020.21.e46 32476320
80 Duan Z, Du FY, Yuan YD, et al. Effects of PM2.5 exposure on Klebsiella pneumoniae clearance in the lungs of rats. Zhonghua Jie He He Hu Xi Za Zhi 2013; 36 : 836–840.24507396
81 Beentjes D, Shears RK, French N, et al. Mechanistic insights into the impact of air pollution on pneumococcal pathogenesis and transmission. Am J Respir Crit Care Med 2022; 206 : 1070–1080. doi:10.1164/rccm.202112-2668TR 35649181
82 Yang L, Li C, Tang X. The impact of PM2.5 on the host defense of respiratory system. Front Cell Dev Biol 2020; 8 : 91. doi:10.3389/fcell.2020.00091 32195248
83 Psoter KJ, De Roos AJ, Wakefield J, et al. Air pollution exposure is associated with MRSA acquisition in young US children with cystic fibrosis. BMC Pulm Med 2017; 17 : 106. doi:10.1186/s12890-017-0449-8 28750627
84 Wang S, Zhou Q, Tian Y, et al. The lung microbiota affects pulmonary inflammation and oxidative stress induced by PM2.5 exposure. Environ Sci Technol 2022; 56 : 12368–12379. doi:10.1021/acs.est.1c08888 35984995
85 Chen YW, Li SW, Lin CD, et al. Fine particulate matter exposure alters pulmonary microbiota composition and aggravates pneumococcus-induced lung pathogenesis. Front Cell Dev Biol 2020; 8 : 570484. doi:10.3389/fcell.2020.570484 33195201
86 Bosch A, Levin E, van Houten MA, et al. Development of upper respiratory tract microbiota in infancy is affected by mode of delivery. EBioMedicine 2016; 9 : 336–345. doi:10.1016/j.ebiom.2016.05.031 27333043
87 Gisler A, Korten I, de Hoogh K, et al. Associations of air pollution and greenness with the nasal microbiota of healthy infants: a longitudinal study. Environ Res 2021; 202 : 111633. doi:10.1016/j.envres.2021.111633 34256075
88 Liu S, Zhang W, Zhang F, et al. TMT-based quantitative proteomics analysis reveals airborne PM2.5-induced pulmonary fibrosis. Int J Environ Res Public Health 2018; 16 : 98. doi:10.3390/ijerph16010098 30602677
89 Zhao C, Pu W, Wazir J, et al. Long-term exposure to PM2.5 aggravates pulmonary fibrosis and acute lung injury by disrupting Nrf2-mediated antioxidant function. Environ Pollut 2022; 313 : 120017. doi:10.1016/j.envpol.2022.120017 36007796
90 Li Y, Lin B, Hao D, et al. Short-term PM2.5 exposure induces transient lung injury and repair. J Hazard Mater 2023; 459 : 132227. doi:10.1016/j.jhazmat.2023.132227 37586238
91 Bourdrel T, Annesi-Maesano I, Alahmad B, et al. The impact of outdoor air pollution on COVID-19: a review of evidence from in vitro, animal, and human studies. Eur Respir Rev 2021; 30 : 200242. doi:10.1183/16000617.0242-2020 33568525
92 Choi J, Shim JJ, Lee MG, et al. Association between air pollution and viral infection in severe acute exacerbation of chronic obstructive pulmonary disease. J Korean Med Sci 2023; 38 : e68. doi:10.3346/jkms.2023.38.e68 36880109
93 Sagawa T, Tsujikawa T, Honda A, et al. Exposure to particulate matter upregulates ACE2 and TMPRSS2 expression in the murine lung. Environ Res 2021; 195 : 110722. doi:10.1016/j.envres.2021.110722 33422505
94 Vos S, De Waele E, Goeminne P, et al. Pre-admission ambient air pollution and blood soot particles predict hospitalisation outcomes in COVID-19 patients. Eur Respir J 2023; 62 : 2300309. doi:10.1183/13993003.00309-2023 37343978
95 Nimmerjahn F, Dudziak D, Dirmeier U, et al. Active NF-κB signalling is a prerequisite for influenza virus infection. J Gen Virol 2004; 85 : 2347–2356. doi:10.1099/vir.0.79958-0 15269376
96 Rui W, Guan L, Zhang F, et al. PM2.5-induced oxidative stress increases adhesion molecules expression in human endothelial cells through the ERK/AKT/NF-κB-dependent pathway. J Appl Toxicol 2016; 36 : 48–59. doi:10.1002/jat.3143 25876056
97 Wang J, Kaplan N, Wysocki J, et al. The ACE2-deficient mouse: a model for a cytokine storm-driven inflammation. FASEB J 2020; 34 : 10505–10515. doi:10.1096/fj.202001020R 32725927
98 Sans M, Panes J, Ardite E, et al. VCAM-1 and ICAM-1 mediate leukocyte-endothelial cell adhesion in rat experimental colitis. Gastroenterology 1999; 116 : 874–883. doi:10.1016/S0016-5085(99)70070-3 10092309
99 Xie Y, Gong C, Bo L, et al. Treg responses are associated with PM2.5-induced exacerbation of viral myocarditis. Inhal Toxicol 2015; 27 : 281–286. doi:10.3109/08958378.2015.1040139 25951053
100 Ma JH, Song SH, Guo M, et al. Long-term exposure to PM2.5 lowers influenza virus resistance via down-regulating pulmonary macrophage Kdm6a and mediates histones modification in IL-6 and IFN-β promoter regions. Biochem Biophys Res Commun 2017; 493 : 1122–1128. doi:10.1016/j.bbrc.2017.09.013 28887033
101 Gu Y, Hsu AC, Pang Z, et al. Role of the innate cytokine storm induced by the influenza a virus. Viral Immunol 2019; 32 : 244–251. doi:10.1089/vim.2019.0032 31188076
102 Qudus MS, Tian M, Sirajuddin S, et al. The roles of critical pro-inflammatory cytokines in the drive of cytokine storm during SARS-CoV-2 infection. J Med Virol 2023; 95 : e28751. doi:10.1002/jmv.28751 37185833
103 Botto L, Lonati E, Russo S, et al. Effects of PM2.5 exposure on the ACE/ACE2 pathway: possible implication in COVID-19 pandemic. Int J Environ Res Public Health 2023; 20 : 4393. doi:10.3390/ijerph20054393 36901403
104 Al Hanai AH, Antkiewicz DS, Hemming JDC, et al. Seasonal variations in the oxidative stress and inflammatory potential of PM2.5 in Tehran using an alveolar macrophage model. The role of chemical composition and sources. Environ Int 2019; 123 : 417–427. doi:10.1016/j.envint.2018.12.023 30622066
105 Zhao Q, Chen H, Yang T, et al. Direct effects of airborne PM2.5 exposure on macrophage polarizations. Biochim Biophys Acta 2016; 1860 : 2835–2843. doi:10.1016/j.bbagen.2016.03.033 27041089
106 Zhao J, Gao Z, Tian Z, et al. The biological effects of individual-level PM2.5 exposure on systemic immunity and inflammatory response in traffic policemen. Occup Environ Med 2013; 70 : 426–431. doi:10.1136/oemed-2012-100864 23322918
107 Zhou Y, Jiang Y, Peng Y, et al. The quantitative and functional changes of postoperative peripheral blood immune cell subsets relate to prognosis of patients with subarachnoid hemorrhage: a preliminary study. World Neurosurg 2017; 108 : 206–215. doi:10.1016/j.wneu.2017.08.091 28866066
108 Gu XY, Chu X, Zeng XL, et al. Effects of PM2.5 exposure on the Notch signaling pathway and immune imbalance in chronic obstructive pulmonary disease. Environ Pollut 2017; 226 : 163–173. doi:10.1016/j.envpol.2017.03.070 28431315
109 Zhang W, Liu X, Zhu Y, et al. Transcriptional and posttranslational regulation of Th17/Treg balance in health and disease. Eur J Immunol 2021; 51 : 2137–2150. doi:10.1002/eji.202048794 34322865
110 Miossec P. Understanding the cytokine storm during COVID-19: contribution of preexisting chronic inflammation. Eur J Rheumatol 2020; 7 : S97–S98. doi:10.5152/eurjrheum.2020.2062 32412405
111 Wu J, Zhu K, Luo X, et al. PM2.5 promotes replication of VSV by ubiquitination degradation of phospho-IRF3 in A549 cells. Toxicol In Vitro 2020; 62 : 104698. doi:10.1016/j.tiv.2019.104698 31669364
112 Weber F, Haller O. Viral suppression of the interferon system. Biochimie 2007; 89 : 836–842. doi:10.1016/j.biochi.2007.01.005 17336442
113 Yang HM, Antonini JM, Barger MW, et al. Diesel exhaust particles suppress macrophage function and slow the pulmonary clearance of Listeria monocytogenes in rats. Environ Health Perspect 2001; 109 : 515–521. doi:10.1289/ehp.01109515 11401764
114 Zhou H, Kobzik L. Effect of concentrated ambient particles on macrophage phagocytosis and killing of Streptococcus pneumoniae. Am J Respir Cell Mol Biol 2007; 36 : 460–465. doi:10.1165/rcmb.2006-0293OC 17079778
115 Mushtaq N, Ezzati M, Hall L, et al. Adhesion of Streptococcus pneumoniae to human airway epithelial cells exposed to urban particulate matter. J Allergy Clin Immunol 2011; 127 : 1236–1242. doi:10.1016/j.jaci.2010.11.039 21247619
116 Hou W, Xu X, Lei Y, et al. The role of the PM2.5-associated metals in pathogenesis of child Mycoplasma Pneumoniae infections: a systematic review. Environ Sci Pollut Res Int 2016; 23 : 10604–10614. doi:10.1007/s11356-016-6535-2 27040534
117 Liu CW, Lee TL, Chen YC, et al. PM2.5-induced oxidative stress increases intercellular adhesion molecule-1 expression in lung epithelial cells through the IL-6/AKT/STAT3/NF-κB-dependent pathway. Part Fibre Toxicol 2018; 15 : 4. doi:10.1186/s12989-018-0240-x 29329563
118 Wang AP. Exposure of PM2.5 exacerbates COVID-19 in vivo. SHS Web Conf 2022; 148 : 03017. doi:10.1051/shsconf/202214803017
119 Dong Z, Ma J, Qiu J, et al. Airborne fine particles drive H1N1 viruses deep into the lower respiratory tract and distant organs. Sci Adv 2023; 9 : eadf2165. doi:10.1126/sciadv.adf2165 37294770
